ATTAINMENT OF COMPLETE RENAL RESPONSE RESULTS IN SIGNIFICANT IMPROVEMENTS IN LUPUS IMPACT TRACKER IN THE AURORA 1 STUDY OF VOCLOSPORIN IN LUPUS NEPHRITIS

被引：0
|
作者：
Jolly, Meenakshi [1 ]
Truman, Matt [2 ]
Hodge, Lucy [2 ]
Lisk, Laura [2 ]
机构：
[1] Rush Univ, Chicago, IL 60612 USA
[2] Aurinia Pharmaceut Inc, Victoria, BC, Canada
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2022年 / 79卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
53
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [21] CLINICAL AND RENAL PATHOLOGICAL FEATURES PREDICTING COMPLETE CLINICAL RESPONSE IN CRESCENTIC LUPUS NEPHRITIS
    Fukui, H.
    Hanaoka, H.
    Saito, K.
    Hiramoto, K.
    Saito, S.
    Kikuchi, J.
    Kaneko, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1490 - 1490
  • [22] Renal response status to predict long-term renal survival in patients with lupus nephritis: results from the Toronto Lupus Cohort
    Urowitz, Murray
    Georgiou, Mary E.
    Touma, Zahi
    Su, Jiandong
    Diaz-Martinez, Juan Pablo
    Fu, Qinggong
    Levy, Roger A.
    Gairy, Kerry
    Anderson, Nicole
    Mackinnon, Anne
    Juliao, Patricia C.
    LUPUS SCIENCE & MEDICINE, 2024, 11 (02):
  • [23] Patient Reported Outcomes Analyses from AURORA 1 Clinical Trial: Lupus Impact Tracker and LupusPRO
    Jolly, Meenakshi
    Truman, Matt
    Flauto, Ronald
    Dao, Kathryn
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3142 - 3144
  • [24] Comparison of Dual-immunosuppressive Therapy with a Voclosporin-based, Triple-immunosuppressive Regimen for Lupus Nephritis in the ALMS and AURORA 1 Studies
    Dall'Era, Maria
    Yap, Ernie
    Truman, Matt
    Hodge, Lucy
    Solomons, Neil
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1571 - 1573
  • [25] Outcomes following immunosuppressive therapy withdrawal after complete renal response in proliferative lupus nephritis
    Vidal-Montal, Paola
    Narvaez, Javier
    Fulladosa, Xavier
    Mitjavila, Francesca
    Capdevila, Olga
    Torras, Joan
    Goma, Montserrat
    Nolla, Joan M.
    LUPUS SCIENCE & MEDICINE, 2025, 12 (01):
  • [26] EARLY REDUCTIONS IN PROTEINURIA WITH VOCLOSPORIN TREATMENT ACROSS LUPUS NEPHRITIS BIOPSY CLASSES: POOLED DATA FROM THE AURA-LV AND AURORA 1 TRIALS
    Askanase, Anca
    Hodge, Lucy
    Birardi, Vanessa
    Leher, Henry
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I820 - I822
  • [27] Early Reductions in Proteinuria with Voclosporin Treatment Across Lupus Nephritis Biopsy Classes: Pooled Data from the AURA-LV and AURORA 1 Trials
    Askanase, Anca
    Hodge, Lucy
    Birardi, Vanessa
    Leher, Henry
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 706 - 708
  • [28] Impact of stringent response in proteinuria on long-term renal outcomes in proliferative lupus nephritis
    Won, J.
    Lee, J. S.
    Oh, J. S.
    Kim, Y-G
    Lee, C-K
    Yoo, B.
    Hong, S.
    LUPUS, 2019, 28 (11) : 1294 - 1301
  • [29] Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
    Rovin, Brad H.
    Teng, Y. K. Onno
    Ginzler, Ellen M.
    Arriens, Cristina
    Caster, Dawn J.
    Romero-Diaz, Juanita
    Gibson, Keisha
    Kaplan, Joshua
    Lisk, Laura
    Navarra, Sandra
    Parikh, Samir V.
    Randhawa, Simrat
    Solomons, Neil
    Huizinga, Robert B.
    LANCET, 2021, 397 (10289): : 2070 - 2080
  • [30] Comparison of complete renal response and mortality in early- and late-onset lupus nephritis: a multicenter retrospective study of a Japanese cohort
    Kunihiro Ichinose
    Mineaki Kitamura
    Shuntaro Sato
    Keita Fujikawa
    Yoshiro Horai
    Naoki Matsuoka
    Masahiko Tsuboi
    Fumiaki Nonaka
    Toshimasa Shimizu
    Remi Sumiyoshi
    Tomohiro Koga
    Shin-ya Kawashiri
    Naoki Iwamoto
    Takashi Igawa
    Mami Tamai
    Hideki Nakamura
    Tomoki Origuchi
    Tomoya Nishino
    Atsushi Kawakami
    Arthritis Research & Therapy, 22
12345